Late Stage Clinical Research Services
In today’s competitive landscape, getting a drug on the market is no longer about meeting clinical trial requirements, receiving regulatory approval and launching the drug. Drug developers need to generate evidence that shows whether a drug works in the real world and the benefit and value it provides to the healthcare system and patient.
Market Access & Real World Evidence
As a result of our holistic approach to Late Stage clinical programs and with our expertise in Product Life Cycle Management, INC Research/inVentiv Health is strategically positioned to collect real world, differentiating product evidence that can prepare our clients to more successfully go to market.
The Patient Centric Approach to Late Stage Trials
INC Research/inVentiv Health offers real world opportunities to interact with trial patients in meaningful and productive ways:
- Pharmacy outreach
- Patient Education
- Patient Advocacy
- Social Media Outreach
- E-Consent Options
- Behavioral Insights and Adherence Programs
- Patient Advisory Boards
- Patient-centric Retention Programs